Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals

Recruiting Observational Study
Sepsis Infections
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 143 Days
Sex
Any
Study type
Observational
Participants needed
40 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background. Bacillus cereus group (Bc) comprises twenty-six closely related species of spore-forming environmental bacteria. Recently, increased sepsis and septic shock caused by Bc were reported in preterm neonates (PN), and the mortality rate can reach up to 30%. Using Whole Genome Sequencing (WGS) increasingly used to characterize Bc strains, The team aimed to determine an accurate identificati…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Premature newborn (i.e born before 37 last menstrual periods) with invasive infection caused by B. cereus (strains isolated from blood culture and cerebrsopinal fluid) Exclusion Criteria: * None
Contacts

Raymond Ruimy

04.92.03.62.20

ruimy.r@chu-nice.fr

CONTACT